Calton & Associates Inc. Takes $361,000 Position in Teleflex Incorporated $TFX

Key Points

• Calton & Associates Inc. acquired a new stake in Teleflex, purchasing 2,610 shares valued at approximately $361,000 in the first quarter.
• Teleflex's quarterly earnings exceeded expectations, with an EPS of $3.73 compared to the consensus estimate of $3.36, indicating a 4.2% revenue increase year-over-year.
• The company's dividend announcement revealed a quarterly payout of $0.34, which translates to an annualized yield of 1.1%, with a payout ratio of 32%.

Calton & Associates Inc. acquired a new position in shares of Teleflex Incorporated (NYSE:TFX - Free Report) during the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor acquired 2,610 shares of the medical technology company's stock, valued at approximately $361,000.

Several other large investors have also recently bought and sold shares of the company. T. Rowe Price Investment Management Inc. lifted its holdings in Teleflex by 0.7% during the 1st quarter. T. Rowe Price Investment Management Inc. now owns 6,216,763 shares of the medical technology company's stock worth $859,095,000 after buying an additional 43,642 shares in the last quarter. Dimensional Fund Advisors LP lifted its holdings in Teleflex by 69.5% during the 1st quarter. Dimensional Fund Advisors LP now owns 867,864 shares of the medical technology company's stock worth $119,927,000 after buying an additional 355,720 shares in the last quarter. Diamond Hill Capital Management Inc. lifted its holdings in Teleflex by 122.8% during the 1st quarter. Diamond Hill Capital Management Inc. now owns 584,586 shares of the medical technology company's stock worth $80,784,000 after buying an additional 322,222 shares in the last quarter. TD Asset Management Inc lifted its holdings in Teleflex by 0.7% during the 1st quarter. TD Asset Management Inc now owns 490,000 shares of the medical technology company's stock worth $67,713,000 after buying an additional 3,310 shares in the last quarter. Finally, Northern Trust Corp lifted its holdings in Teleflex by 15.2% during the 4th quarter. Northern Trust Corp now owns 462,846 shares of the medical technology company's stock worth $82,377,000 after buying an additional 61,219 shares in the last quarter. Institutional investors and hedge funds own 95.62% of the company's stock.

Wall Street Analysts Forecast Growth

Several research analysts have issued reports on the company. Mizuho upped their price objective on Teleflex from $130.00 to $135.00 and gave the stock a "neutral" rating in a report on Friday, August 1st. Wells Fargo & Company reduced their price target on Teleflex from $137.00 to $131.00 and set an "equal weight" rating on the stock in a research report on Friday, August 1st. Wall Street Zen lowered Teleflex from a "strong-buy" rating to a "buy" rating in a research report on Saturday, August 30th. Finally, Royal Bank Of Canada raised their price target on Teleflex from $130.00 to $135.00 and gave the stock a "sector perform" rating in a research report on Friday, August 1st. One research analyst has rated the stock with a Buy rating, eight have given a Hold rating and one has issued a Sell rating to the company's stock. According to MarketBeat.com, Teleflex currently has an average rating of "Hold" and an average price target of $141.57.

Teleflex Trading Up 1.2%

Teleflex stock traded up $1.53 during mid-day trading on Friday, hitting $130.62. 572,983 shares of the company's stock were exchanged, compared to its average volume of 778,530. The firm has a market capitalization of $5.77 billion, a P/E ratio of 30.73, a PEG ratio of 1.76 and a beta of 1.08. Teleflex Incorporated has a fifty-two week low of $108.90 and a fifty-two week high of $249.90. The company has a quick ratio of 1.44, a current ratio of 2.41 and a debt-to-equity ratio of 0.42. The company's 50 day simple moving average is $119.69 and its 200-day simple moving average is $128.27.

Teleflex (NYSE:TFX - Get Free Report) last issued its quarterly earnings data on Thursday, July 31st. The medical technology company reported $3.73 EPS for the quarter, topping the consensus estimate of $3.36 by $0.37. Teleflex had a return on equity of 15.08% and a net margin of 6.31%.The business had revenue of $780.90 million for the quarter, compared to the consensus estimate of $771.53 million. During the same quarter last year, the business posted $3.42 EPS. The firm's revenue was up 4.2% compared to the same quarter last year. Teleflex has set its FY 2025 guidance at 13.900-14.300 EPS. On average, equities analysts anticipate that Teleflex Incorporated will post 13.98 earnings per share for the current year.

Teleflex Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Monday, September 15th. Shareholders of record on Friday, August 15th will be paid a $0.34 dividend. The ex-dividend date of this dividend is Friday, August 15th. This represents a $1.36 annualized dividend and a dividend yield of 1.0%. Teleflex's dividend payout ratio (DPR) is currently 32.00%.

Insider Transactions at Teleflex

In other news, Director Jaewon Ryu purchased 1,500 shares of the company's stock in a transaction on Tuesday, August 5th. The shares were purchased at an average price of $115.00 per share, with a total value of $172,500.00. Following the purchase, the director directly owned 3,727 shares of the company's stock, valued at $428,605. This trade represents a 67.36% increase in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Also, Director Gretchen R. Haggerty purchased 500 shares of the company's stock in a transaction on Wednesday, August 6th. The stock was purchased at an average cost of $114.75 per share, for a total transaction of $57,375.00. Following the purchase, the director directly owned 6,305 shares in the company, valued at approximately $723,498.75. This trade represents a 8.61% increase in their ownership of the stock. The disclosure for this purchase can be found here. Over the last three months, insiders have acquired 5,500 shares of company stock worth $633,590. 1.40% of the stock is currently owned by company insiders.

About Teleflex

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.